BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37757895)

  • 1. Complication Profiles of Smooth vs Textured Tissue Expanders in Breast Reconstruction: A Systematic Review and Meta-Analysis.
    Fijany AJ; Chaker SC; Hung YC; Zago I; Friedlich N; Olsson SE; Holan CA; Montorfano L; Mubang RN; Givechian KB; Boctor MJ; Pekarev M; Martinez-Jorge J; Slater ED
    Aesthet Surg J; 2024 Mar; 44(4):383-393. PubMed ID: 37757895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Tissue Expander Surface Texture on Two-Stage Breast Reconstruction Outcomes: A Combined Analysis.
    Park BC; Alving-Trinh AL; Prigmore HL; Harrell FE; Sarhane K; Joseph JT; Thomas H; Lupi AL; Perdikis G; Higdon KK
    Plast Reconstr Surg; 2024 Jun; 153(6):1053e-1062e. PubMed ID: 37252917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Unusual Case of BIA-ALCL Associated with Prolonged/Complicated Biocell-Textured Expander, followed by Smooth Round Breast Implant Exposure, and Concurrent Use of Adalimumab.
    Akhavan AA; Wirtz EC; Ollila DW; Bhatt N
    Plast Reconstr Surg; 2021 Aug; 148(2):299-303. PubMed ID: 34133406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Breast Implant-Associated Anaplastic Large Cell Lymphoma in Patients with Textured Tissue Expanders.
    Nelson JA; McKernan CD; Rubenstein RN; Shamsunder MG; Poulton R; Dabic S; Mehrara BJ; Disa JJ; Cordeiro PG; McCarthy CM
    Plast Reconstr Surg; 2023 Jul; 152(1):32-37. PubMed ID: 36728202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes Analysis of Textured Versus Smooth Tissue Expanders in Breast Reconstruction.
    Di Valerio E; Rao AN; Leyngold M; Carlson J; O'Neill D; Virk S; Mast B; Satteson E
    Ann Plast Surg; 2022 Dec; 89(6):622-625. PubMed ID: 36416686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smooth Versus Textured Tissue Expander Breast Reconstruction: Complications and Efficacy.
    McLaughlin C; Hughes AJ; Parham CS; Fritsche M; Potochny JD; Kunselman A; Ravnic DJ
    Ann Plast Surg; 2022 May; 88(3 Suppl 3):S288-S292. PubMed ID: 35513333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smooth versus textured tissue expanders in breast reconstruction - A retrospective review of post-operative surgical site infections.
    Tevlin R; Cemaj SL; Azad AD; Borrelli MR; Silverstein ML; Posternak V; Nguyen D; Lee GK; Nazerali RS
    J Plast Reconstr Aesthet Surg; 2022 Sep; 75(9):3060-3067. PubMed ID: 35768293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smooth vs Textured Expanders: Patient Factors and Anatomic Plane Are Greater Factors in Determining First-Stage Breast Reconstruction Outcomes.
    Dahmus ES; Ruffino AE; Madera JD; Long A; Wang S; Kauffman CA; Devitt S; Sanders C; DeSantis J
    Aesthet Surg J; 2024 Jan; 44(2):NP159-NP167. PubMed ID: 37706322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BIA-ALCL and Textured Breast Implants: A Systematic Review of Evidence Supporting Surgical Risk Management Strategies.
    Nelson JA; McCarthy C; Dabic S; Polanco T; Chilov M; Mehrara BJ; Disa JJ
    Plast Reconstr Surg; 2021 May; 147(5S):7S-13S. PubMed ID: 33890875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured breast implants.
    Cordeiro PG; Ghione P; Ni A; Hu Q; Ganesan N; Galasso N; Dogan A; Horwitz SM
    J Plast Reconstr Aesthet Surg; 2020 May; 73(5):841-846. PubMed ID: 32008941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Risk Estimate of Breast Implant-Associated Anaplastic Large Cell Lymphoma in Textured Breast Implants.
    Collett DJ; Rakhorst H; Lennox P; Magnusson M; Cooter R; Deva AK
    Plast Reconstr Surg; 2019 Mar; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):30S-40S. PubMed ID: 30817554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast Reconstruction Following Breast Implant-Associated Anaplastic Large Cell Lymphoma.
    Lamaris GA; Butler CE; Deva AK; Miranda RN; Hunt KK; Connell T; Lipa JE; Clemens MW
    Plast Reconstr Surg; 2019 Mar; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):51S-58S. PubMed ID: 30817556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological Profile in Portugal of Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Cross-Sectional Study.
    Cunha A; Horta R; Barreiro D
    Acta Med Port; 2021 Aug; 34(9):572-579. PubMed ID: 33512315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast implant-associated anaplastic large cell lymphoma: A comprehensive review.
    Marra A; Viale G; Pileri SA; Pravettoni G; Viale G; De Lorenzi F; Nolè F; Veronesi P; Curigliano G
    Cancer Treat Rev; 2020 Mar; 84():101963. PubMed ID: 31958739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EUSOMA position regarding breast implant associated anaplastic large cell lymphoma (BIA-ALCL) and the use of textured implants.
    Cardoso MJ; Wyld L; Rubio IT; Leidenius M; Curigliano G; Cutuli B; Marotti L; Biganzoli L
    Breast; 2019 Apr; 44():90-93. PubMed ID: 30703669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Textured versus Smooth Tissue Expanders: A Comparison of Complications in 3526 Breast Reconstructions.
    Nelson JA; Rubenstein RN; Vorstenbosch J; Haglich K; Poulton RT; McGriff D; Stern CS; Coriddi M; Cordeiro PG; McCarthy CM; Disa JJ; Mehrara BJ; Matros E
    Plast Reconstr Surg; 2024 Feb; 153(2):262e-272e. PubMed ID: 37104467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast Implant-Associated Anaplastic Large Cell Lymphoma in Australia: A Longitudinal Study of Implant and Other Related Risk Factors.
    Loch-Wilkinson A; Beath KJ; Magnusson MR; Cooter R; Shaw K; French J; Vickery K; Prince HM; Deva AK
    Aesthet Surg J; 2020 Jul; 40(8):838-846. PubMed ID: 31738381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast implant associated anaplastic large cell lymphoma: The UK experience. Recommendations on its management and implications for informed consent.
    Johnson L; O'Donoghue JM; McLean N; Turton P; Khan AA; Turner SD; Lennard A; Collis N; Butterworth M; Gui G; Bristol J; Hurren J; Smith S; Grover K; Spyrou G; Krupa K; Azmy IA; Young IE; Staiano JJ; Khalil H; MacNeill FA
    Eur J Surg Oncol; 2017 Aug; 43(8):1393-1401. PubMed ID: 28596034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma in the United States: A Systematic Review.
    Santanelli di Pompeo F; Clemens MW; Paolini G; Firmani G; Panagiotakos D; Sorotos M
    Aesthet Surg J; 2023 Dec; 44(1):NP32-NP40. PubMed ID: 37616552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in Human Leukocyte Antigen Expression Between Breast Implant-Associated Anaplastic Large Cell Lymphoma Patients and the General Population.
    Tevis SE; Hunt KK; Miranda RN; Lange C; Butler CE; Clemens MW
    Aesthet Surg J; 2019 Sep; 39(10):1065-1070. PubMed ID: 30715139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.